Clinical Trial Update: DPP4-Inhibitors and Bone Metabolism in Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting completion of a study evaluating DPP-4 inhibitors and bone metabolism in adults with type 2 diabetes, including osteoporosis and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis
• Type 2 Diabetes Mellitus

Drugs mentioned

• Galvus (vildagliptin)
• Januvia (sitagliptin)
• Nesina (alogliptin)
• Tradjenta (Linagliptin)

Snippet

Sponsor: Azienda Policlinico Umberto I | Conditions: Osteoporosis, Bone Loss, Postmenopausal | Phase 3 | Status: COMPLETED